Rate : Actualité Rate en direct - P24 | Bourse Reflex
Accueil > Tags > Rate

  • Toutes les actualités en rapport avec « Rate »

14/04 09:00 Rate - Roslin Cellab Selects BioCision's CoolCell for Cryopreservation of Human Embryonic Stem Cell Lines

13/04 22:30 Rate - Publication d'une étude scientifique in vivo révolutionnaire : le TA-65 augmente la durée vie, permet le renouvellement des systèmes d'organes et le rallongement des télomères trop courts

12/04 10:00 Rate - Dow Jones Unveils New Innovations to Factiva

11/04 09:30 Rate - NASDAQ OMX Group and IntercontinentalExchange Respond to NYSE Euronext Board's Summary Rejection of Superior Proposal

05/04 18:55 Rate - Apricus Biosciences' CEO Interviewed by WallStreetCorner.com

05/04 07:00 Rate - Eurofins announces successful closing of Lancaster acquisition

01/04 13:30 Rate - NASDAQ OMX Group Inc. and IntercontinentalExchange Propose Superior Transaction to Acquire NYSE Euronext for USD 42.50 Per Share, 19% Premium to Deutsche Boerse Proposal

31/03 18:00 Rate - 2010: A winning strategy and remarkable results

30/03 00:00 Rate - Les investisseurs accumulent timidement

29/03 18:30 Rate - Agreement for the rollout of electronic shelf labels in 70 additional stores of the Monoprix group in France

27/03 11:12 Rate - Les enseignes de bricolage se cassent les dents sur le marché chinois

23/03 18:20 Rate - 2010 financial results : Current operating income: up 44.6% to EUR 12.7 million

23/03 08:15 Rate - 2010 results and outlook

22/03 21:45 Rate - 2010: Turnaround Annual consolidated results

22/03 19:30 Rate - OrbusNeich poursuit le Dr Pavel Cervinka pour diffamation

22/03 14:55 Rate - Apricus Biosciences Announces Poster Presentations on Progress of PrevOnco(TM) in Combination With NexACT(R) Technology at the American Association for Cancer Research 2011 Annual Meeting

21/03 18:00 Rate - 2010 annual results : Recurring operating margin of 16.6%

21/03 11:40 Rate - Deutsche Telekom enterre un rêve américain devenu cauchemar stratégique

18/03 20:00 Rate - 2010 Annual results : Strong Growth in Net Profit to EUR 8.1 million

15/03 15:30 Rate - Apricus Biosciences Announces Formation of Clinical Advisory Board as Part of Its Plans to Further the Clinical Development of Femprox(R)